Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumorsMing Yi, Kongming Wu, Mengke Niu et al.|Journal of Hematology & Oncology|2022Cited by 178